QuartzBio

QuartzBio is the Precision Medicine Intelligence Company, purpose-built to deliver end-to-end Sample and Biomarker Intelligence for clinical-stage biopharma teams. Powered by a network of domain-specific AI agents, QuartzBio's first-in-class Precision Medicine AI Agent Platform transforms fragmented data into actionable intelligence, enabling teams to conversationally interact with their unified ecosystem of clinical, sample, and biomarker data to gain real-time insights.

QuartzBio serves the entire precision medicine value chain, with 25% of top pharmaceutical companies and 20% of top biotechnology companies already using the platform. Users report turning data into insights in seconds rather than the hours or days required by traditional workflows — a greater than 10x speed improvement — and 90% of surveyed users in sample and biomarker operations roles agree that a conversational AI virtual assistant is helpful for their day-to-day workflow.

Core Solutions

• Sample Intelligence: Provides a 360° view of clinical trial biospecimens across their entire lifecycle, from initial collection through to long-term storage, enabling comprehensive biospecimen management for clinical teams.
• Biomarker Intelligence: Delivers a 360° view of biomarker data across its full lifecycle, covering data acquisition, quality control, indexing, and mapping, giving teams complete visibility into their biomarker data ecosystem.
• Agent Intelligence: Provides 360° insights across sample and biomarker data ecosystems, powered by a user's own AI virtual assistant, enabling conversational querying and autonomous data ingestion across precision medicine operations.

Platform Capabilities

• Autonomous data ingestion across clinical, sample, and biomarker data sources
• Conversational AI interface allowing users to interact with their data ecosystem in natural language
• Domain-specific AI agent network purpose-built for precision medicine workflows
• Real-time insights delivered through a unified, connected data ecosystem
• Elimination of reliance on manual, spreadsheet-based workflows in sample and biomarker operations

Compliance and Customer Validation

• QuartzBio has addressed compliance considerations in the AI age, with resources focused on how intelligent agents help mitigate regulatory risk
• The platform carries a Net Promoter Score of 8, based on customer experience and recommendation surveys asking users how likely they are to recommend the technology to colleagues in the industry
• Customers span multiple biopharma oncology groups, with adoption across both top pharma and top biotech organizations globally
• QUARTZBIO® is a registered trademark of Precision Regulatory and Translational Sciences, Inc., operating as QuartzBio, in the United States and other jurisdictions

QuartzBio continues to advance the precision medicine field by replacing fragmented, manual data processes with an intelligent, conversational platform that connects sample, clinical, and biomarker data into a single actionable ecosystem for biopharma teams.